|
ZNF322B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024420E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.275900E-02 |
| Normal-vs-Stage2 |
1.720800E-01 |
| Normal-vs-Stage3 |
6.198300E-02 |
| Normal-vs-Stage4 |
8.829600E-02 |
| Stage1-vs-Stage2 |
8.237000E-01 |
| Stage1-vs-Stage3 |
6.731200E-01 |
| Stage1-vs-Stage4 |
2.324600E-01 |
| Stage2-vs-Stage3 |
9.090600E-01 |
| Stage2-vs-Stage4 |
4.294600E-01 |
| Stage3-vs-Stage4 |
4.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.813900E-02 |
| Normal-vs-AfricanAmerican |
6.041600E-04 |
| Normal-vs-Asian |
1.397440E-01 |
| Caucasian-vs-AfricanAmerican |
1.833690E-02 |
| Caucasian-vs-Asian |
6.559200E-01 |
| AfricanAmerican-vs-Asian |
7.056000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.806300E-02 |
| Normal-vs-Female |
5.659000E-03 |
| Male-vs-Female |
1.338570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.369900E-02 |
| Normal-vs-Extreme_Weight |
1.444350E-01 |
| Normal-vs-Obese |
1.658310E-02 |
| Normal-vs-Extreme_Obese |
2.753800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.063600E-01 |
| Normal_Weight-vs-Obese |
6.301600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.929200E-01 |
| Extreme_Weight-vs-Obese |
3.405000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.329600E-01 |
| Obese-vs-Extreme_Obese |
6.709200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.580200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.201700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.643230E-01 |
| Normal-vs-Age(81-100Yrs) |
3.192400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.426600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.488800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.533800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.613900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.818600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.552200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.225850E-02 |
| Normal-VS-Type2 PRCC |
3.126600E-01 |
| Normal-VS-KIRP CIMP |
2.203600E-02 |
| Normal-VS-Unclassified PRCC |
1.436770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.828780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.907200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.978200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.749570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.204800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.047400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.848800E-01 |
| Normal-vs-N1 |
4.395800E-04 |
| Normal-vs-N2 |
8.671200E-01 |
| N0-vs-N1 |
4.974700E-04 |
| N0-vs-N2 |
9.032800E-01 |
| N1-vs-N2 |
1.208820E-01 |
|
|
